These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5063113)

  • 21. The fate of the hydrolysis products of thalidomide in the pregnant rabbit.
    Fabro S; Smith RL; Williams RT
    Biochem J; 1967 Aug; 104(2):570-4. PubMed ID: 6048799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of D- and L-thalidomide and related studies.
    Shealy YF; Opliger CE; Montgomery JA
    J Pharm Sci; 1968 May; 57(5):757-64. PubMed ID: 5657531
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation.
    Miyata M; Tamura E; Motoki K; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2003 Apr; 31(4):469-75. PubMed ID: 12642474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.
    Contino-Pépin C; Parat A; Périno S; Lenoir C; Vidal M; Galons H; Karlik S; Pucci B
    Bioorg Med Chem Lett; 2009 Feb; 19(3):878-81. PubMed ID: 19103485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide revisited.
    Robertson GM
    J Okla State Med Assoc; 1972 Feb; 65(2):45-50. PubMed ID: 4551370
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].
    Blaschke G; Kraft HP; Fickentscher K; Köhler F
    Arzneimittelforschung; 1979; 29(10):1640-2. PubMed ID: 583234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide and its analogues as cyclooxygenase inhibitors.
    Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross coupling.
    Stewart SG; Spagnolo D; Polomska ME; Sin M; Karimi M; Abraham LJ
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5819-24. PubMed ID: 17851074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis of racemates and enantiomers of 3-alkylthalidomide analogs and determination of their absolute configuration].
    Knabe J; Omlor G
    Arch Pharm (Weinheim); 1989 Aug; 322(8):499-505. PubMed ID: 2604538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug toxicity in the animal fetus.
    McColl JD
    Appl Ther; 1967 Nov; 9(11):915-7. PubMed ID: 4964963
    [No Abstract]   [Full Text] [Related]  

  • 32. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
    Lee CJ; Gonçalves LL; Wells PG
    FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and teratogenic action of n-hydroxythalidomide].
    Blaschke G; Hess HR; Lüpke NP
    Arzneimittelforschung; 1989 Mar; 39(3):293-4. PubMed ID: 2757654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.
    Turk BE; Jiang H; Liu JO
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7552-6. PubMed ID: 8755512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intermolecular interaction of folic acid with N-phthaloyl-DL-glutamic acid. Teratogenic effect of thalidomide].
    Eckert T; Dörr NW
    Experientia; 1971 Jun; 27(6):671-2. PubMed ID: 5556452
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thalidomide: a review of the literature].
    dos Santos Júnior MF; Lombardi C; Belda W
    Hansenol Int; 1981 Dec; 6(2):136-45. PubMed ID: 7349301
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomides.
    Yamamoto T; Shibata N; Sukeguchi D; Takashima M; Nakamura S; Toru T; Matsunaga N; Hara H; Tanaka M; Obata T; Sasaki T
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3973-6. PubMed ID: 19297157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative effect of thalidomide and relative substances on the growth of HeLa cells.
    Mori T; Kitagawa H
    Chem Pharm Bull (Tokyo); 1968 Nov; 16(11):2289-92. PubMed ID: 5721309
    [No Abstract]   [Full Text] [Related]  

  • 40. Alterations of rat liver phospholipid composition induced by oral thalidomide.
    Kalofoutis A; Monastirli A; Papapanagiotou A; Georgiou S; Pasmatzi E; Sakkis T; Bolsen K; Goerz G; Merk HF; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 1999; 12(6):312-6. PubMed ID: 10545827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.